Fluid behind the eye doesn’t go away with home remedies or eye drops. It requires professional treatment tailored to the specific condition causing the buildup. The good news: most cases respond well to modern therapies, and some resolve on their own within a few months. The key is identifying what’s driving the fluid, because the treatment path differs significantly depending on the cause.
What Causes Fluid to Build Up Behind the Eye
When doctors talk about “fluid behind the eye,” they’re usually referring to fluid collecting beneath or within the retina, the light-sensitive tissue lining the back of your eye. Three conditions account for the vast majority of cases.
Central serous chorioretinopathy (CSR) is the most common cause in younger adults, typically affecting people in their 30s to 50s. Fluid leaks through a weak spot in the tissue layer beneath the retina, creating a small pocket of detachment. It’s strongly linked to stress and elevated cortisol levels. Any form of corticosteroid medication, whether oral, inhaled, nasal spray, injected into a joint, or even applied to the skin, can trigger it. Pregnancy and Cushing’s syndrome are additional risk factors, both tied to cortisol’s effect on the eye.
Macular edema occurs when fluid accumulates within the retinal layers themselves, most often as a complication of diabetes or retinal vein blockages. The blood vessels in the retina become leaky, allowing fluid to swell the central vision area (the macula).
Wet age-related macular degeneration (AMD) involves abnormal blood vessels growing beneath the retina, leaking fluid and blood. In clinical trials, 70% to 85% of patients with wet AMD already have fluid under the retina at the time of diagnosis.
When Fluid Resolves on Its Own
If you’ve been diagnosed with acute CSR, there’s a reasonable chance your eye will heal without intervention. Most acute cases resolve spontaneously within two to three months, and the outer limit is typically six months. In studies comparing treatment to observation, 56% to 58% of untreated eyes cleared the fluid within the study period.
During this waiting period, your doctor will likely schedule follow-up visits to monitor progress with imaging scans. The main thing you can do is address modifiable risk factors: reduce psychological stress where possible and, critically, talk to your doctor about any corticosteroid medications you’re using. Even inhaled steroids for asthma or a topical cream for eczema can sustain the problem. Stopping or switching the steroid, when medically safe, is often the most effective step you can take.
Macular edema and wet AMD do not resolve on their own. Both conditions require active treatment to prevent permanent vision loss.
Eye Injections: The Primary Treatment
For macular edema and wet AMD, the standard treatment is a series of injections directly into the eye. These use medications that block a protein called VEGF, which drives abnormal blood vessel growth and leakage. The three most commonly used are bevacizumab, ranibizumab, and aflibercept.
The injection itself takes only seconds and is done in your eye doctor’s office after numbing drops. What patients need to prepare for is the frequency: a typical course involves around 13 injections over two years. Most treatment plans start with monthly injections for the first few months to get the fluid under control, then gradually extend the interval based on how your eye responds. This “treat and extend” approach lets your doctor find the longest gap between injections that still keeps fluid from returning.
A newer option, faricimab, targets two pathways instead of one. In large clinical trials of patients with diabetic macular edema, faricimab cleared fluid from inside the retina roughly 10 months faster than aflibercept. Patients also needed fewer injections on average to reach that point. This dual-action approach is becoming an increasingly common first choice, particularly for patients who respond slowly to older medications.
Light-Based Therapies for CSR
When CSR doesn’t resolve on its own or keeps recurring, two light-based procedures can help.
Photodynamic therapy (PDT) is the most effective option. A light-sensitive medication is injected into a vein in your arm, then a low-energy laser activates it at the back of your eye to seal the leaking area. In one major trial, 95% of patients treated with PDT had no remaining fluid at 12 months, compared to 58% in the observation group. The treatment uses a reduced dose of the medication to minimize side effects.
Subthreshold laser uses very low-power laser pulses applied to the area of fluid accumulation, careful to avoid the center of your vision. It’s gentler than traditional laser and doesn’t leave visible burns. In a comparative study, 72% of patients treated with subthreshold laser achieved 20/20 vision at six months, versus 56% of those who simply waited.
Both procedures are outpatient, take less than 30 minutes, and require no downtime beyond some light sensitivity for a day or two after PDT.
Surgery for Stubborn Cases
When fluid persists despite repeated injections or laser therapy, surgery becomes an option. A vitrectomy removes the gel-like substance filling the eye’s interior, which can relieve traction on the retina and allow fluid to drain. The surgeon may also peel a thin membrane from the retinal surface to improve results. Studies confirm that adding this peeling step is more effective at stabilizing vision and reducing fluid than vitrectomy alone.
The catch is that vitrectomy reliably reduces retinal thickness and clears fluid, but vision improvement is less predictable. The reason is straightforward: by the time surgery is considered, many patients already have some permanent damage to the retinal layers from prolonged fluid exposure. Imaging scans taken before surgery can help predict who is most likely to benefit. Patients whose retinal layers still show good structural integrity tend to have better visual outcomes. This is why doctors increasingly recommend not waiting too long before considering surgery if injections aren’t working.
How Doctors Track Your Progress
Optical coherence tomography, or OCT, is the workhorse of fluid monitoring. It’s a painless scan that takes seconds and produces a cross-sectional image of your retina in microscopic detail. Fluid shows up as dark pockets on the scan, and your doctor can measure both retinal thickness and the proportion of fluid within the tissue to gauge treatment response.
Retinal thickness is the most common metric doctors track between visits. A decrease means fluid is draining. An increase means it’s returning. Newer analysis methods that measure the percentage of fluid relative to total retinal area are even more sensitive to small changes, helping doctors catch a relapse before you notice any vision shift.
Monitoring Your Vision at Home
Between appointments, an Amsler grid is a simple tool that can alert you to fluid changes before your next scan. It’s a square grid of evenly spaced lines with a dot in the center, available as a printed card or smartphone app.
To use it, hold the grid at normal reading distance (12 to 15 inches) with your glasses or contacts on. Cover one eye and stare at the center dot without moving your gaze. While focused on the dot, check whether all four corners are visible, all lines appear perfectly straight, no areas look dark or blank, and no lines are blurred or faded. Then repeat with the other eye. If any lines appear wavy, bent, or missing, that can signal new or worsening fluid. Your eye specialist may ask you to do this daily.
Catching a change early matters because fluid that sits beneath or within the retina for months can cause progressive, irreversible damage to the light-sensing cells. The faster you respond to a shift, the better your odds of preserving sharp central vision long term.